Therapeutic impact of 18F-FDG PET/CT in recurrent differentiated thyroid carcinoma

被引:0
|
作者
Fabio Pomerri
Anna Rita Cervino
Faise Al Bunni
Laura Evangelista
Pier Carlo Muzzio
机构
[1] Veneto Institute of Oncology IOV-IRCCS,Department of Medicine
[2] Oncologic Radiology Unit,undefined
[3] University of Padua,undefined
[4] Veneto Institute of Oncology IOV-IRCCS,undefined
[5] Radiotherapy and Nuclear Medicine Unit,undefined
来源
La radiologia medica | 2014年 / 119卷
关键词
Thyroid carcinoma; Positron emission tomography/computed tomography; Thyroglobulin;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:97 / 102
页数:5
相关论文
共 50 条
  • [21] Role of 18F-FDG PET/CT in management of patients with differentiated thyroid cancer
    Sibille, L.
    Guillemard, S.
    Eberle-Pouzeratte, M. -C.
    Thezenas, S.
    Espitalier-Riviere, C.
    Faurous, P.
    Lamy, P. -J.
    Rossi, M.
    Artus, J. -C.
    MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE, 2010, 34 (02): : 78 - 87
  • [22] Is it practical and cost effective to detect differentiated thyroid carcinoma metastases by 18F-FDG PET/CT, by 18F-FDG SPET/CT or by 131I SPET/CT?
    He, Xinjia
    Wang, Xucai
    Yu, Jinming
    Ma, Chao
    HELLENIC JOURNAL OF NUCLEAR MEDICINE, 2015, 18 (01): : 2 - 4
  • [23] Association Between 18F-FDG PET/CT and Thyroglobulin Doubling-Time in Differentiated Thyroid Carcinoma
    Costa, G.
    Lapa, P.
    Martins, H.
    Albuquerque, A.
    Pedroso de Lima, J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S222 - S223
  • [24] Comparison of 18F-FLT PET/CT and 18F-FDG PET/CT in detection of metastases of differentiated thyroid cancer
    Kato, K.
    Abe, S.
    Odagawa, T.
    Fujita, Y.
    Niwa, A.
    Iwano, S.
    Ito, S.
    Ikeda, M.
    Naganawa, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 : S263 - S263
  • [25] 18F-FDG PET/CT under TSH stimulation in the diagnosis of recurrence and metastases of differentiated thyroid carcinoma
    Koranda, P.
    Crhakova, H.
    Formanek, R.
    Buriankova, E.
    Henzlova, L.
    Kaminek, M.
    Myslivecek, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 : S112 - S112
  • [26] Role of 18F-FDG PET/CT in Detecting Recurrent Gallbladder Carcinoma
    Kumar, Rakesh
    Sharma, Punit
    Kumari, Anita
    Halanaik, Dhanapathi
    Malhotra, Arun
    CLINICAL NUCLEAR MEDICINE, 2012, 37 (05) : 431 - 435
  • [27] Recombinant thyrotropin stimulation improves 18F-FDG PET/CT sensitivity in patients with recurrent differentiated thyroid cancer
    Panareo, Stefano
    Rossi, Roberta
    Cittanti, Corrado
    Giganti, Melchiore
    Prandini, Napoleone
    Franceschetti, Paola
    De Biasi, Vincenzo
    Lunardon, Silvia
    Feggi, Luciano
    JOURNAL OF NUCLEAR MEDICINE, 2011, 52
  • [28] Poorly Differentiated Primary Carcinoma of the Middle Ear on 18F-FDG PET/CT
    Nemer, John S.
    Hsieh, Meng-Chieh P.
    Chen, Diane
    O'Toole, Kathleen M.
    Yeh, Randy
    CLINICAL NUCLEAR MEDICINE, 2019, 44 (01) : E43 - E45
  • [29] Clinical Relevance of 18F-FDG PET and 18F-DOPA PET in Recurrent Medullary Thyroid Carcinoma
    Verbeek, Hans H. G.
    Plukker, John T. M.
    Koopmans, Klaas Pieter
    de Groot, Jan Willem B.
    Hofstra, Robert M. W.
    Kobold, Anneke C. Muller
    van der Horst-Schrivers, Anouk N. A.
    Brouwers, Adrienne H.
    Links, Thera P.
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53 (12) : 1863 - 1871
  • [30] The Performance of 18F-FDG PET and 18F-FDG PET/CT in Detection of Carcinoma of Unknown Primary
    Dong, M.
    Zhao, K.
    Zhao, J.
    Guan, Y.
    Liu, Z.
    Ruan, L.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 : S275 - S275